{
  "folder": "IC-074",
  "content": "{{knowledge objective\n|Identifiant=OIC-074-15-A\n|Item_parent=Prescription and monitoring of psychotropic drugs (see item 330)\n|Item_parent_short=Prescription and monitoring of psychotropic drugs (see item 330)\n|Rank=A\n|Heading=Anxiolytics: knowledge of frequent or serious adverse effects, main drug interactions at all stages of life, particularly in elderly patients.\n|Description=None\n|Rubric=Management\n|Contributors=\n|Order=15}}\n\n\n==Undesirable effects==\n{| class=\"wikitable\"\n|+\nFor all: possible allergic reactions.\n<br />\n|'''Chemical class'''\n|'''Adverse reactions'''\n|'''Management'''\n|-\n| rowspan=\"7\" |'''Benzodiazepines'''\n|Sedation :\n\n*Daytime sleepiness, asthenia, dizziness, impaired alertness.\n*Potentiated by alcohol\n|\n*Patient information, particularly with regard to driving.\n*Adaptation of doses\n|-\n|Cognitive alterations :\n\n*memory impairment and impaired reaction capacity\n*Confusion may occur in the elderly\n|\n*Adaptation of doses, cautious discontinuation if confusion.\n|-\n|\n*Behavioural disorders favoured by alcohol:\n*Disinhibiting effect\n| rowspan=\"3\" |\n*Do not combine with alcohol\n*Contraindicated for subsequent prescription of benzodiazepines.\n|-\n|\n*Paradoxical reactions favoured by alcohol\n*Agitation and aggression\n|-\n|\n*Amnesic automatic actions: in impulsive patients, which may have medico-legal consequences.\n|-\n|\n*Pharmacological dependence and withdrawal syndrome when treatment is stopped.\n*Use disorder\n|\n*Respect the rules for stopping treatment (gradual reduction).\n|-\n|\n*Anxiety rises when treatment is stopped\n|\n*Monitoring progress\n|-\n|Azapirones\n|\n*Nausea, headache at the start of treatment\n|\n*Wait, symptomatic treatment\n|-\n|H1 antihistamine\n|\n*Sedation, daytime somnolence, asthenia, dizziness, impaired alertness.\n*Potentiated by alcohol\n*QT prolongation\n|\n*Patient information, particularly with regard to driving.\n*Adaptation of doses\n|}\n\n== Main drug interactions\n\n* There are no formally contraindicated associations with benzodiazepines, but certain pharmacodynamics must be taken into account: potentiation of sedative effects by any other CNS depressant.\n* Antihistamines: avoid combinations with other anticholinergics and other CNS depressants.",
  "question": {
    "question": "Which of the following is NOT a recommended management strategy for benzodiazepine-related adverse effects in elderly patients?",
    "option_a": "Patient information regarding the effects on driving.",
    "option_b": "Gradual reduction of doses to prevent withdrawal syndrome.",
    "option_c": "Combination with alcohol to enhance therapeutic effects.",
    "option_d": "Cautious discontinuation if confusion or behavioral disorders occur.",
    "correct_option": "c"
  }
}